Hirudin biosimilar (Rhein-Minapharm)

水蛭素生物类似药 (Rhein-Minapharm)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHirudin biosimilar (Rhein-Minapharm)
Drug Alias Name水蛭素生物仿制药 (Rhein-Minapharm)Thrombexx
ClassificationBiologics > Biosimilar
Mechanisms of ActionProthrombin inhibitors
TargetsProthrombin
Therapy Area/IndicationsVenous Thrombosis
Global Approved IndicationsVenous Thrombosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEgypt
Original Approved Date2006/10/01
Country/TerritoryEgypt
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesRhein Minapharm Biogenetics
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsVenous Thrombosis
Inactive IndicationsN/A

Other Information

ATC CodeB01AX
Related LinksN/A